TRUE PARTNER (08657) announced its interim results, with total revenue of HKD 215,000, a decrease of 96% year-on-year.
TRUE PARTNER (08657) announced its interim results for the six months ending June 30, 2026, with total revenue of HK$215,000, a year-on-year decrease of 96%; the loss attributable to shareholders was HK$15,969,000; basic loss per share was HK$0.0334.
TRUE PARTNER (08657) announced its interim results for the six months ending June 30, 2026, with total revenue of HKD 215,000, a year-on-year decrease of 96%; a loss attributable to shareholders of HKD 15.969 million; and a basic loss per share of HKD 0.0334.
Related Articles

After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).
After Cursor was acquired by SpaceX (SPCX.US), OpenAI announced the termination of cooperation citing Musk's "breach of contract history."

Electra Therapeutics (ETRA.US) has submitted an IPO application for the U.S. stock market, leveraging the current biotech IPO boom to advance the development of new drugs for immune diseases and cancer.

Blue Owl (OWL.US) has teamed up with PIMCO to customize a $2.4 billion GPU financing for IREN (IREN.US).

RECOMMEND





